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Abstract. Prediabetes is considered as the initial phase of macrovaskular disease associated with increase of 
blood glucose and cholesterol level. The effect of propolis to treat fasting blood glucose, glucose tolerance, 
total cholesterol was examined. Experimental  Research  with Randomized Clinical Trial (RCT) design was 
utilized in the study. Intervention given was propolis at dose 50 mg/kg bwt and health education 
administered for 20 days. The quality of propolis was 20%extract and quercetin content 25.29 mg/L tested 
by Biofarmaka Laboratory Test of Hasanuddin University, health education used counseling strategy. The 
samples were 64 prediabetic patients consist of 32 patients treated with propolis and 32 treated with health 
education. The result of Wilcoxon with significant level of 0.05 has proved significantly decreased fasting 
blood glucose, glucose tolerance and total cholesterol respectively 14.28 (p=0.000), 23.16 (p=0.000) and 
16.3 (p=0.000) The result of group given propolis as significant as health education group respectively 
fasting blood glucose 14.9 (p=0.001), glucose tolerance 13.98 (p=0.000) and total cholesterol 9.76 
(p=0.021). Giving propolis and health education are effective for the change of fasting blood glucose, 
glucose tolerance and total cholesterol. Propolis is potential to use  as  a pharmacology therapy for 
prediabetes. 
Keywords: Propolis, Fasting Blood Glucose, Glucose Tolerance, Total cholesterol 
Introduction 
Prediabetes defined as  blood sugar level higher than normal, but not high enough to be 
diagnosed as diabetes and Its raises a person’s risk of type 2 diabetes, heart disease and 
stroke. Prediabetes states include impaired glucose tolerance (IGT), impaired fasting 
glucose (IFG), and the metabolic syndrome (CDC, 2011; Garber et al, 2008). Prediabetes 
associated with an increase risk of cancer death, particularly death from liver cancer. 
Mortality from all cancers rose linearly with increasing glucose concentration (Zhou et al. 
2010). Prevalence of prediabetes is increasing worldwide and experts have projected that 
more than 470 million people will have prediabetes by 2030 (Tabak et al, 2012).  Report on 
result of Basic National Health Research (RISKESDAS) 2007 showed IGT in Urban Area  was 
10.5%, the center of Indonesia, Jakarta was 24.91%, West papua was 21.8%, West 
Sulawesi 21.8% and South Sulawesi 17.6%. Prevalence of prediabetes in Indonesia is high 
(10%) so that a good prevention strategy is needed (Basic Health Survey, 2007). 
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 Prediabetes needs proper intervention to reduce diabetes incidence and others 
complication. The best solution is lifestyle modification but it is so difficult for many people 
to do, so medicine treatment is needed.  Propolis is a resinous substance produced by 
honeybees. It has been reported to possess various biological activities such as anticancer, 
antioxidant and  hypolipidemic. It was reported that propolis supplementation in STZ-
induced diabetes is associated with a significant decrease in the blood glucose (Viuda-
martos et al. 2008: Al-Hariri, 2011). New Zealand rabbits were fed during four weeks had 
significant reduced in total cholesterol, low density lipoprotein, trygliceride and increased 
high density lipoprotein (Nader Et al, 2010). We need evidence based On clinical trial about 
potencial hypoglycemic and anticholesterol effect of propolis to prediabetes patient. 
Materials and Methods 
Design and Subject 
Pretest Posttest Experimental Research design was utilized in the study. Sixty four (64) 
subjects were chosen randomly. The chosen subjects were then divided equally. Thirty two 
(32) subjects belong to the experimental group who received the Propolis intervention, 
while the other thirty two (32) subjects belong to the Control group who received the Health 
education intervention. The laboratory personnel and the subjects were not informed on 
who will be included in both experimental and control groups to prevent bias. The 
experiment proper held at Great Hall Health Laboratory of Makasaar (ISO 1705:2008 
Certified), lasted for twenty (20) days.  
Procedure 
Prior to the procedure, this paper was submitted to the Ethical Commission of Hasanuddin 
University, and it was approved by the said Committee with the recommendation number 
0260/H4.8.4.5.31/PP36-KOMETIK 2012 and registration number UH12010025. The first 
step was screening 120 subjects and out of these subjects only 64 subjects were diagnosed 
to have prediabetes.  These subjects then were given informed consent for their approval 
and participation in the study. Consequently, these subjects were randomly grouped into 
Experimental and Control Groups. Both Experimental and Control groups were pretested 
with Glucose Tolerance (mg/dl), Fasting Blood Glucose (mg/dl) and Total Cholesterol. It was 
then followed by the Intervention phase, in which the Experimental group received the 
propolis intervention, specifically propolis extract 20% containing quercetin content 25.29 
mg/L. A total of 6 drops were given to the subjects, 2 drops in the morning, another 2 drops 
in the afternoon and the last 2 drops was given during night. On the other hand, the control 
group received the Health education intervention regarding information about prediabetes, 
prevention of complication, diet and physical activity. Twenty (20) days, after the 
Intervention phase, posttest with Glucose Tolerance (mg/dl), Fasting Blood Glucose (mg/dl) 
and Total Cholesterol were taken and consequently compared with pretest results. 
Results and Discussion 
Data were analyzed and interpreted utilizing statistical tools such as  mean, standard 
deviation,   mean difference and characteristic of subjects. Statistic test used was Wilcoxon 
text (α =0.05). 
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Tabel 1 Characteristic of Subjects 
  Treatment Control 
Characteristics  Mean (%) Mean (SD) 
  n=32 n=32 
Sex 
 
 
Ethnic 
 
 
 
 
Education 
 
 
 
Age 
 
Family History 
 
Male 
Female 
 
Buginese 
Javanese 
Makassar 
Toraja 
 
Academy/University 
High School 
Under High school 
 
 
 
Yes 
No 
3 (9.4) 
29 (90.6) 
 
25 (78.1) 
2 (6.3) 
5 (15.6) 
- 
 
13 (40.6) 
9 (28.1) 
10 (31.2) 
 
45.66(14.86) 
 
28(87.5) 
4(12.5) 
3 (9.4) 
29 (90.6) 
 
18 (56.3) 
2 (6.3) 
11 (34.4) 
1 (3.1) 
 
9 (28.1) 
11 (34.3) 
12 (37.5) 
 
44.88(14.16) 
 
25 (78.1) 
7(21.9) 
  
Table 1 showed that majority of subjects both in experimental and control groups 
were female and both got the rate of 29 (90.6%). Buginese ethnic got the highest score 
among the ethnic groups. For the Educational attainment, 13 subjects (40.6 %) of the 
treatment group reached Academy/University or College level, while 12 subjects (37.5%) of 
the Control group reached under high school level. Majority of the subjects both in 
treatment and control groups had a family history of prediabetes.   
Some studies about prediabetes have explain Characteristics of Prediabetes 
prevalence in Indonesia. The majority of prediabetes in Indonesia are females (61.6%), 
Seen on age bases, most of the pre-diabetes subjects are in an age range between 38 – 47. 
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If we account 66.4% under high school (Soewondo 2011). Having a family history of 
diabetes and being older are major risk factors of developing prediabetes (Kumar et al, 
2008: Soegondo, 2011). Prediabetes Epidemiological study in Depok has result that Isolated 
Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are more frequently 
found in female subjects (66.2 and 69%) (Yunir et al, 2009). 
 Studies that Ethnicity plays a role in the different prevalences of diabetes and 
prediabetes are in Amsterdan and among the three ethnic groups in Chinese, it is showed 
significantly different. (Ujcic-Voortman et al, 2009 ;Yang Feng et al, 2012).   
Table 2. Effect of Propolis to Prediabetes after 20 Days Treatment 
  Perlakuan Kontrol 
Variabel Mean (SD)  
∆ 
Mean 
 
P 
Mean (SD)  
P 
∆ 
Mean  Pre Post 
 
Pre Post 
Glucose 
Tolerance 
(mg/dl) 
Fasting Blood 
Glucose(mg/dl) 
 
Total 
Cholesterol 
 
148.19±14.056 
 
 
 
103.31±14.92 
 
 
195.16±23.49 
125.03±19.30 
 
 
 
89.03±12.79 
 
 
178.63±16.99 
-
23.16 
 
 
-
14.28 
 
 
-16.3 
0.000 
 
 
 
0.000 
 
 
0.000 
143.28±17.81 
 
 
 
102.84±19.672 
 
 
198.6±21.13 
129.03±27.09 
 
 
 
 
88.75±14.54 
 
 
 
188.84±14.82 
0.000 
 
 
 
 
0.001 
 
 
 
0.021 
- 
13.98 
 
 
 
-14.9 
 
 
 
-9.76 
Minus  (-) in mean difference (∆ Mean)  means decrease 
SD  =  Deviation standart 
 Table 2 clearly showed that there was a significant decrease in all the variables 
being investigated namely Glucose Tolerance (mg/dl), Fasting Blood Glucose (mg/dl) and 
Total Cholesterol in both the Treatment/Experimental and Control groups. Therefore, it is 
suffice to say that both propolis intervention and Health Education on prediabetes, 
prevention of complication, diet and physical activity can decrease both the blood sugar and 
cholesterol levels of prediabetes individuals. These findings are correlated with the following 
explanations; Lifestyle modification is still the best intervention for prediabetes, but many 
people  are undisciplined or not adherent to lifestyle modifications, so it needs alternative 
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intervention and one  of these is the administration of propolis to human subjects  which 
has proven  to decrease blood glucose and total cholesterol of prediabetes patients. 
 Compunds identified in propolis were amino acids, aromatic acids, aromatic esters, 
flavones and flavonols terpenoid, steroid, etc (Marcucci, 1995).  Propolis contains some 
minerals such as Mg, Ca, I, K,Na, Cu, Zn, Mn and Fe as well as some vitamins like B1,B2, 
B6, C and E, and a number of fatty acids. In addition, it contains some enzymes as succinic 
dehydrogenase, glucose-6-phosphatase, adenosine triphosphatase and acid phosphatase 
(Tikhonov et al, 1987).  
 Propolis consist of many substances such as amino acids, flavones and 
flavonoids, terpenoids and other compounds, vitamins and minerals. Some of substances 
have benefit to prediabetes. Quercetin has proven exist in propolis by testing in Biofarmaka 
laboratorium of Hasanuddin University, each propolis almost contain quercetin but in 
defferent level.  Based on many evidences or research and theoritically, quercetin can 
decrease blood glucose and has strong antioxidant effect to oxidative stress.  Quercetin, a 
flavonoid with antioxidant properties brings the regeneration of the pancreatic islets and 
probably increases insulin release in streptozocin-induced diabetic, thus exerting its 
beneficial antidiabetic effects (Vessal et al, 2003). It assumes has protective roles against 
mulltple diseases associated with oxidative stress, quercetin affects adipogenesis and 
apoptosis in 3T3-L1 cells  by activating monophosphate-activated protein kinase (AMPK) 
signal pathway in 3T3-L1 preadipocytes (Ahn et al, 2008).  
 One of the propolis composition is chromium, many studies shown chromium have 
beneficial effects without any documented side effects on glucose tolerance state and type 2 
DM. The mechanism of actions of chromium involves increased insulin binding, increased 
insulin receptor number and increased insulin receptor phosporylation (Anderson, 1998). 
Propolis has proven effective in control blood glucose, modulate lipid metabolism and 
improve the insulin sensitivity (Li Yajing et al, 2010; El-Sayed et al, 2009:Zamami et al, 
2007). It also has effect to stress oxidative or free radicals in rats with diabetes mellitus 
(Fuliang et al, 2005: Bhadauria et al, 2007). Propolis as a food supplement modulated 
antioxidant enzymes (AOE) and significantly decreased lipid peroxidation processes (LPO) in 
plasma, liver, lungs, and brain of mice (Sobocanec et al, 2006). Free Amino acids exist in 
propolis are arginine and prolin (Gabrys, 2006). Total cholesterol prediabetes patient 
treated with propolis also decreased significant, based on research and theoritically arginine 
contained in propolis has effect as anti atherogenic. Propolis Evidence by research  about 
effect propolis has proven decreased total cholesterol (Abo-salem et al, 2009). Polyphenols 
from propolis are able to reduce atherosclerotic lesions through mechanisms including the 
modulation of inflammatory and angiogenic factors (Daleprane et al, 2012). 
Conclusions 
Health Education has been found out to be effective in decreasing both the blood sugar and 
cholesterol  levels, therefore it is important that the Health care team will carry out their 
role as adviser, counsellor and educator. Propolis has both antihypoglycemic and 
anticholesterol effects.Therefore, it is highly recommended that further studies should focus 
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on the the product development of propolis, specifying the effective and safe dose for all 
ages, side effects and toxicity level of the said product.   
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